Log in or Sign up for Free to view tailored content for your specialty!
Optometry News
Student loans: Let’s talk about SAVE
The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.
VIDEO: Axitinib implant addresses sustainability in wet AMD
In this Healio Video Perspective from the ASRS meeting, Pravin U. Dugel, MD, of Ocular Therapeutix discusses the phase 3 program for Axpaxli, an axitinib implant for wet age-related macular degeneration.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues
In this Healio Video Perspective from the ASRS meeting, Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema.
VIDEO: Phase 3 bel-sar trial focuses on choroidal melanoma
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Jill Hopkins, MD, of Aura Biosciences discusses a phase 3 program in ocular oncology.
Q&A: 72% of eye drop medication wasted due to ‘self-imposed use cessation dates’
Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.
4D-150 reduces annualized anti-VEGF injection rate in wet AMD at 24 weeks
One intravitreal injection of 4D-150 helped reduce the mean annualized anti-VEGF injection rate in patients with wet age-related macular degeneration, according to a study presented at the American Society of Retina Specialists meeting.
VIDEO: ONL1204 slows geographic atrophy lesion growth in phase 1b study
In this Healio Video Perspective from the ASRS meeting, Durga Borkar, MD, of Duke University Eye Center presents data from a phase 1b study investigating ONL1204, a Fas inhibitor, for geographic atrophy.
Topical antibiotics may be overprescribed in children with conjunctivitis
Overtreating acute conjunctivitis with topical antibiotics may contribute to antibiotic resistance with no improvement in outcomes, according to a research letter published in JAMA Ophthalmology.
Safety, efficacy consistent in Luxturna post-authorization study
Interim safety data from a post-authorization study of Luxturna in patients with genetic retinal diseases were consistent with clinical trial data, according to a presentation at the American Society of Retina Specialists annual meeting.
AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD
Taking a daily supplement with antioxidant vitamins and minerals may slow the progression of late-stage dry age-related macular degeneration and could help maintain central vision in affected patients, according to researchers at NIH.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read